Literature DB >> 9337696

Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas.

M Mandai1, I Konishi, H Kuroda, M Fukumoto, T Komatsu, S Yamamoto, K Nanbu, C V Rao, T Mori.   

Abstract

The mRNA expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptors was analysed by the RT-nested PCR method in five normal ovarian tissues, 62 ovarian tumours (5 benign, 7 borderline and 43 malignant epithelial tumours, 3 sex cord-stromal tumours and 4 germ cell tumours) and in 2 ovarian cancer cell lines. In normal ovaries, two cDNA fragments of different sizes were detected using primers designed to amplify a region including exon 9. Sequencing revealed that the larger fragment was derived from a full-length receptor, while the smaller fragment was a splice variant lacking exon 9. In ovarian tumours, the larger fragment of LH/hCG receptors was detected in 40% of the epithelial ovarian carcinomas, none of the germ cell tumours, all of the sex cord-stromal tumours and one of the 2 ovarian cancer cell lines. Immunohistochemistry confirmed the localisation of LH/hCG receptor protein in the tumour cells which correlated with mRNA expression. Patients with full-length LH/hCG receptors in carcinomas showed a better prognosis compared with those without the receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337696     DOI: 10.1016/s0959-8049(97)00166-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  The LH/hCG Axis in Endometrial Cancer: A New Target in the Treatment of Recurrent or Metastatic Disease.

Authors:  A Arcangeli; I Noci; A Fortunato; G F Scarselli
Journal:  Obstet Gynecol Int       Date:  2010-07-15

Review 2.  Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.

Authors:  Meike Körner; Laurence J Miller
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

3.  Targeting granzyme B to tumor cells using a yoked human chorionic gonadotropin.

Authors:  Isao Kanatani; Xinjian Lin; Xiaoqin Yuan; Gerald Manorek; Xiying Shang; Lawrence H Cheung; Michael G Rosenblum; Stephen B Howell
Journal:  Cancer Chemother Pharmacol       Date:  2011-02-16       Impact factor: 3.333

4.  Ovarian VEGF(165)b expression regulates follicular development, corpus luteum function and fertility.

Authors:  Y Qiu; M Seager; A Osman; J Castle-Miller; H Bevan; D J Tortonese; D Murphy; S J Harper; H M Fraser; L F Donaldson; D O Bates
Journal:  Reproduction       Date:  2012-01-09       Impact factor: 3.906

5.  Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC).

Authors:  Zheng Feng; Hao Wen; Xingzhu Ju; Rui Bi; Xiaojun Chen; Wentao Yang; Xiaohua Wu
Journal:  J Ovarian Res       Date:  2017-01-25       Impact factor: 4.234

6.  Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.

Authors:  Shigang Xiong; Paulette Mhawech-Fauceglia; Denice Tsao-Wei; Lynda Roman; Rajesh K Gaur; Alan L Epstein; Jacek Pinski
Journal:  BMC Cancer       Date:  2019-11-15       Impact factor: 4.430

7.  A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.

Authors:  Zheng Feng; Hao Wen; Rui Bi; Xingzhu Ju; Xiaojun Chen; Wentao Yang; Xiaohua Wu
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.